ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Philips and Gibraltar Health Authority announce 16-year strategic partnership, transforming patient imaging and cardiac care at St Bernard’s Hospital

March 07, 2023

For the first time, patients will no longer need to travel abroad for treatment of acute cardiac diseases, as the Gibraltar Health Authority prepares to provide local coronary angiography and angioplasty services in a new interventional cardiac suite

Amsterdam, the Netherlands and Gibraltar – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the Gibraltar Health Authority, today announced they have signed a long-term strategic partnership continuing their long-standing relationship and marking ambitions to advance radiology and cardiology patient care. As part of the agreement, the building of a brand-new interventional cardiac suite (cath lab) will commence later this year. The construction and installation of this specialist equipment will take approximately 9-12 months and will be accompanied by a service agreement to ensure ongoing maintenance of the equipment.

Gibraltar’s newly improved services will bring sustainable benefits for patients at St Bernard’s Hospital, with developments expected to lead to more cardiac patients receiving local treatment, instead of traveling across the border to neighboring Spain. Expected clinical outcomes include reduced length of stays for such patients, relieving pressure on demand for hospital beds and ambulance transport services, and improvement in 30-day mortality rates.

The new interventional suite will bring St Bernard’s Hospital’s services up to full operating capacity, allowing more patients to receive a range of cardiology treatments such as coronary angioplasty, catheterization to treat artery blockages and minimally invasive replacement of heart valves. In parallel, existing Philips systems within the hospital will be upgraded with the latest technology, including the replacement of equipment in two X-ray rooms, a fluoroscopy room for real-time moving X-ray imagery and ultrasound systems. As part of the agreement, a new CT system will reduce downtime and delays in diagnostics whilst creating opportunities for St Bernard’s cardiology and radiology teams to further expand services. This could see the Gibraltar Health Authority continue to bring care closer to home for future patients, such as through the availability of coronary CT scanning.

“This new chapter in our partnership with the Gibraltar Health Authority will give both clinicians and the community of Gibraltar access to innovative technologies beyond the next decade,” said Mark Leftwich, Managing Director for Philips UK and Ireland. “For the first time, clinical staff will be able to manage acute cardiac diseases, such as heart attacks, in a purpose-built suite, whilst Philips imaging systems and informatics will enable faster scanning time and enhanced collaboration. This will help create more efficiency and capacity within the departments and improved image quality will support safer diagnosis.” 

Professor Patrick Geoghegan OBE, Director General Gibraltar Health Authority said: “We are delighted to renew and strengthen our relationship with Philips with this new partnership. The impact that this new diagnostic equipment will have on our operation and on the quality of care we will be able to provide for our community is huge. Gibraltar Health Authority continues to strive to provide the best healthcare to the people of Gibraltar.”

For further information, please contact:

Joost Maltha 
Philips Global Press Office 
Tel: +31 6 10 55 8116  
E-mail: joost.maltha@philips.com

Dominique Monaghan
Philips UK and Ireland Press Office
Tel: +44 7975 755 514
E-mail: dominique.monaghan@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

About Gibraltar Health Authority
The GHA delivers Primary, Secondary and Mental Health Care in Gibraltar. It uses a Healthcare model closely linked to the NHS, and for this purpose some tertiary referrals are delivered in the NHS as well as in Spanish hospitals due to the proximity.

Attachments


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.25
+0.28 (0.12%)
AAPL  268.82
+0.01 (0.01%)
AMD  260.82
+1.15 (0.44%)
BAC  52.84
-0.18 (-0.34%)
GOOG  268.35
-1.58 (-0.59%)
META  752.20
+1.38 (0.18%)
MSFT  544.54
+13.02 (2.45%)
NVDA  192.88
+1.39 (0.73%)
ORCL  282.38
+0.99 (0.35%)
TSLA  462.83
+10.41 (2.30%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.